Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEAP: LMWH vs Aspirin Post-partum
NCT05058924Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Aug 2021
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin in venous thromboembolism (VTE) (2 arms), sponsored by Mount Sinai Hospital. Primary endpoints: Enrollment Rate at 1 year, Consent Rate at 1 year and 3 more. Started Aug 2021; status: completed.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT05058924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05058924.